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論文題目 Investigation of the role of prostaglandin D2 in tumor microenvironment 
    （腫瘍微小環境におけるプロスタグランジン D2の役割解明） 
Background and Aim 
 Tumor microenvironment, which is composed of non-tumor cells such as ECs and 
immune cells, has a key role in tumor growth and metastasis. Tumor cells manipulate this 
microenvironment to acquire adequate nutrients/oxygen and also avoid host 
immunosurveillance. 
 PGD2 is one of major PGs that is synthesized by COX and L- or H-PGDS, and 
produced PGD2 exerts its bioactivity through two receptors, DP and CRTH2. PGD2 has 
been known to regulate physiological sleep, allodynia response, and some allergic diseases. 
Besides, our group recently reported the anti-inflammatory role of H-PGDS-derived PGD2 
in dermatitis, rheumatoid arthritis, acute lung injury, food allergy, pulmonary fibrosis, and 
anaphylaxis. We also found that mast cell H-PGDS-derived PGD2 inhibited the growth of 
mice LLC by attenuating tumor vascular permeability and angiogenesis. However, there are 
still uncertain whether L-PGDS-derived PGD2 regulates tumor growth and PGD2 affects 
tumor metastasis. 
Results 
  In comprehensive analysis of mice melanoma ECs, I found marked increase in 
mRNA expression of L-PGDS compared to the normal ECs. Immunostaining of mice 
melanoma revealed protein expression of L-PGDS in the ECs. In situ hybridization also 
showed mRNA expression of L-PGDS in the ECs of human melanoma and oral squamous 
cell carcinoma. In vitro experiments showed that stimulation with tumor cell-derived IL-1 
and TNF-α increased mRNA expression of L-PGDS and production of PGD2 in the human 
normal ECs. I also investigated the contribution of L-PGDS-PGD2 to tumor growth and 
vascularization. Systemic or EC-specific deficiency of L-PGDS accelerated the growth of 
melanoma in mice, while the treatment with a PGD2 receptor DP agonist attenuated it. 
Morphological and in vivo studies showed that endothelial L-PGDS deficiency showed 
functional changes of tumor ECs such as accelerated vascular hyper-permeability, 
angiogenesis, and EndMT in tumors, which in turn reduced tumor cell apoptosis.  
Conclusion 
 In tumor growth, endothelial L-PGDS-derived PGD2 attenuated the growth of mice 
melanoma through inhibition of tumor vascular permeability, angiogenesis, and EndMT. 
This study provides a significant insight on tumor microenvironment and might lead to a 
novel therapeutic strategy against tumor growth and metastasis. 
